T N Higgins1, G B Blakney, J Dayton. 1. Dynacare Kasper Medical Laboratories, T5V 1B4, Edmonton, Alberta, Canada. Higgins@dkml.com
Abstract
OBJECTIVES: To evaluate the analytical performance of the Bio-Rad Variant II HbA(1C) analyzer (a completely automated system for the quantification of glycohemoglobin [HbA(1C)] in blood). DESIGN AND METHODS: The analytical parameters of precision, linearity and analytical range were assessed and HbA(1C) results from the Variant II were compared to HbA(1C) results from the Bio-Rad Variant (a method certified by the National Glycohemoglobin Standardization Program). The effect of a variety of hemoglobin variants on HbA(1C) obtained on the system was investigated. RESULTS: Total imprecision was less than 5% and the results compared well with those from an established method. The method has a wide analytical range with no carryover between specimens. CONCLUSION: The HbA(1C) method on the Variant II gives acceptable analytical performance.
OBJECTIVES: To evaluate the analytical performance of the Bio-Rad Variant II HbA(1C) analyzer (a completely automated system for the quantification of glycohemoglobin [HbA(1C)] in blood). DESIGN AND METHODS: The analytical parameters of precision, linearity and analytical range were assessed and HbA(1C) results from the Variant II were compared to HbA(1C) results from the Bio-Rad Variant (a method certified by the National Glycohemoglobin Standardization Program). The effect of a variety of hemoglobin variants on HbA(1C) obtained on the system was investigated. RESULTS: Total imprecision was less than 5% and the results compared well with those from an established method. The method has a wide analytical range with no carryover between specimens. CONCLUSION: The HbA(1C) method on the Variant II gives acceptable analytical performance.
Authors: Oleg Sidorenkov; Odd Nilssen; Tormod Brenn; Sergey Martiushov; Vadim L Arkhipovsky; Andrej M Grjibovski Journal: BMC Public Health Date: 2010-01-19 Impact factor: 3.295
Authors: Hassan S Dashti; Céline Vetter; Jacqueline M Lane; Matt C Smith; Andrew R Wood; Michael N Weedon; Martin K Rutter; Marta Garaulet; Frank A J L Scheer; Richa Saxena Journal: Diabetes Date: 2019-11-22 Impact factor: 9.461